BIRC5 and ovarian carcinoma: We found that BIRC3 expression correlated inversely with ovarian cancer patient outcome, while BIRC2, BIRC4, BIRC5, and BIRC7 had no significant impact on patient outcome (Fig. 5e and Supplementary Figure S1).